Sagimet Biosciences (SGMT) Change in Cash (2022 - 2024)

Sagimet Biosciences' Change in Cash history runs 3 years deep, the most recent figure standing at -$80.8 million for Q2 2024.

• On a quarterly basis, Change in Cash fell 1409.85% year-over-year to -$80.8 million in Q2 2024; TTM through Jun 2024 was $4.3 million, a 97.48% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, up 114.43% from the prior year.
• Change in Cash retreated to -$80.8 million in Q2 2024 per SGMT's latest filing, from $101.6 million in the prior quarter.
• Across five years, Change in Cash topped out at $156.2 million in Q4 2022 and bottomed at -$99.8 million in Q4 2023.
• The 3-year median for Change in Cash is $9.2 million (2023), against an average of $22.1 million.
• Across the five-year window, Change in Cash jumped 3830.26% in 2023 and tumbled 1409.85% in 2024, its largest moves.
• Year by year, Change in Cash stood at $156.2 million in 2022, then tumbled by 163.9% to -$99.8 million in 2023, then climbed by 19.03% to -$80.8 million in 2024.
• Per Business Quant, the three latest SGMT Change in Cash figures stand at -$80.8 million (Q2 2024), $101.6 million (Q1 2024), and -$99.8 million (Q4 2023).